On 12/7/23, Wave Life Sciences Ltd (NASDAQ: WVE) stock suffered a major decline of -30.4%, closing at $4.78. Moreover, exceptionally high trading volume at 1268% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -8.8% during the last week.
Current PriceTarget Research Rating
WVE’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
Wave Life Sciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment